Thomas Catinazzo

Chief Financial Officer

Thomas Catinazzo (Chief Financial Officer) filed 9 Form 4 reports in the trailing twelve months (0 purchases, 9 sales), most often in Relay Therapeutics, Inc. (RLAY). The largest single filing was $3.2M of RLAY (187,163 sh across 4 lots, as filed), executed Jun 22.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 9 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$5.1M

shares × price, as filed

Last traded

Sep 8

Filed Sep 9

Median ADV $74.0M across their filed names

Open performance→

Volume by month

Buys $0 Sells $5.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 9 filings

Sector per market data · by filing · past 12 months

Most traded names

RLAY

Relay Therapeutics, Inc. RLAY · 0 buys · 10 sells 10 filings

Recent filings

RLAYSALE Relay Therapeutics, Inc. View filing → $336K
17,717 sh × $18.94
Exec Sep 8
Filed Sep 9 · 4:15 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $350K
17,717 sh × $19.74
Exec Aug 14
Filed Aug 18 · 4:16 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $331K
17,717 sh × $18.69
Exec Jul 6
Filed Jul 8 · 5:07 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $3.2M
187,163 sh across 4 lots
Exec Jun 22
Filed Jun 24 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $228K
17,717 sh × $12.86
Exec May 14
Filed May 14 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $230K
17,717 sh × $13.01
Exec Apr 7
Filed Apr 9 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $178K
17,717 sh × $10.06
Exec Mar 9
Filed Mar 11 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $105K
13,820 sh × $7.62
Exec Jan 27
Filed Jan 29 · 5:30 PM ET More filings →